Press Archive
- Charles Francis: Weakening eye surgery laws places WV patients in jeopardy
- Mark D. Mayle, MD - 2022 Secretariat Award Recipients
- Dr. Larry Schwab recognized with 2020 International Blindness Prevention Award
- Wow Moment with Joseph A. LoCasio | Bio-Tissue | #WowWednesdays
- WVU Today | Moore, Oppe named recipients of Heebink award for Distinguished Service
- Cornea Transplant Restores Young Boy’s Sight After Fishing Accident
- Keep your eyes healthy and safe in the workplace
- Glaucoma Awareness Month
- Ophthalmologists Say 90 Percent of Work-Related Eye Injuries Can be Avoided by Wearing Eye Protection
- Five Tips to Avoid Toy-Related Eye Injuries
- Details
An aldehyde-binding eye drop showed it can significantly reduce ocular itching and tearing.
Read more: Novel eye drop for allergic conjunctivitis shows promise
- Details
Medidur, an injectable insert that provides sustained release of flucinolone acetonide for 3 years, helps prevent recurrence of posterior uveitis.
Read more: Sustained-release corticosteroid for uveitis shows promise
- Details
This non-randomized clinical trial assessed the efficacy of 2% ibopamine, a topical drug that temporarily increases aqueous production, for diagnosing glaucoma.
Read more: Ibopamine challenge test can diagnose glaucoma stages
- Details
This retrospective review shows that the introduction of corneal collagen crosslinking may have reduced the number of keratoplasty procedures for keratoconus.
- Details
The FDA has issued a final guidance document for industry and FDA staff on minimally invasive glaucoma surgical (MIGS) devices.
- Details
Ocular Therapeutix announced promising topline results from a phase 2 clinical trial of sustained-released dexamethasone for inflammatory dry eye disease.
Read more: Sustained-released dexamethasone shows promise in dry eye